文献速递慢性静脉疾病静脉血栓栓塞

非恶性下腔静脉梗阻的血管内再通治疗

Endovascular recanalization for nonmalignant obstruction of the inferior vena cava.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2018-01-11

本研究回顾性分析了66例因非恶性疾病导致下腔静脉和/或髂静脉慢性闭塞接受血管内再通的患者,技术成功率高,无死亡或临床显著肺栓塞,36个月一期通畅率78%、二期通畅率91%,83%患者症状缓解,高凝状态是再闭塞的唯一预测因素。

要点

  • 血管内再通联合支架置入治疗非恶性下腔静脉慢性闭塞安全可行,36个月通畅率良好。
  • 83%患者症状缓解,无死亡或临床显著肺栓塞发生。
  • 高凝状态是再通血管再闭塞的唯一预测因素。

核心结论

  • 对于非恶性症状性下腔静脉及合并髂股静脉梗阻,球囊扩张和自膨式支架置入的血管内再通技术具有挑战性但安全持久。
  • 本回顾性研究中36个月估计通畅率超过85%,临床结果优良。
  • 在考虑开放手术重建前,应尝试对慢性非恶性下腔静脉及合并髂或髂股静脉梗阻进行静脉支架置入。

研究设计与样本

  • 回顾性研究,纳入2001年1月至2014年12月在本医疗中心接受下腔静脉伴或不伴髂静脉血管内再通的66例患者。

主要发现

  • CEAP分级3、4a、4b、5、6级分别有41、2、1、2、20例,平均静脉临床严重程度评分为12.4±6.5。
  • 梗阻累及肾下下腔静脉44例,累及肾下及肾上下腔静脉22例。
  • 支架置入前后压力梯度分别为6.7±4.0 mmHg和0.9±1.1 mmHg(P < .001),首次和二次再通尝试的手术成功率分别为90%和100%。

临床怎么用

  • 对于非恶性慢性下腔静脉及合并髂股静脉梗阻,可优先考虑血管内再通和支架置入。
  • 术后需长期抗凝,并关注高凝状态患者的再闭塞风险。

局限性

  • 回顾性研究设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to evaluate outcomes of endovascular recanalization of the inferior vena cava (IVC) and iliac veins with long-standing chronic venous obstruction caused by nonmalignant disease. METHODS: Medical records for 66 patients who underwent endovascular recanalization of the IVC with or without iliac veins from January 2001 to December 2014 at our medical center were retrospectively reviewed. Primary outcomes included morbidity and mortality; secondary outcomes included primary, primary assisted, and secondary patency and resolution of symptoms. RESULTS: Forty-five (68%) patients were male; the mean age was 43 years (range, 17-83 years). All but one patient had chronic symptoms (mean duration, 8 ± 9 years). Clinical, Etiology, Anatomy, and Pathophysiology classes included 3, 4a, 4b, 5, and 6 in 41, 2, 1, 2, and 20 patients, respectively. Mean Venous Clinical Severity Score was 12.4 ± 6.5. Fifty-nine patients (89%) had history of deep venous thrombosis, and 13 also had pulmonary embolism. Twenty-five patients (38%) had an IVC filter; 20 (30%) had thrombophilia. The obstruction involved the infrarenal IVC in 44 patients and both the infrarenal and suprarenal IVC in 22 patients. All recanalizations were performed under conscious sedation and local anesthesia and involved sequential angioplasty and stent placement into the IVC, with or without iliac vein stenting. Venous access included bilateral femoral veins and right internal jugular vein. Stents used were Wallstents (Boston Scientific, Marlborough, Mass; n = 70), Protegé stents (ev3, Plymouth, Minn; n = 49), Gianturco (Cook Medical, Bloomington, Ind; n = 44), and Luminexx (Bard, Tempe, Ariz; n = 1). Pressure gradients were 6.7 ± 4.0 mm Hg before and 0.9 ± 1.1 mm Hg after stenting (P < .001). Procedural success was 90% and 100% at first and second attempt at recanalization, respectively. There was no mortality or clinically significant pulmonary embolism. Four patients had five complications: two developed an arteriovenous fistula, one patient developed groin hematoma that required open evacuation, and one had peri-IVC hematoma and femoral vein thrombosis that required repeated angioplasty and stenting; 93% of patients received long-term anticoagulation. Follow-up was 42 ± 36 months. Four patients were lost to follow-up. Primary patency, primary assisted patency, and secondary patency at 36 months were 78%, 87%, and 91%, respectively. Symptoms resolved in 83% of patients. On multivariable regression analysis, hypercoagulable state was the only predictor of reocclusion of the recanalized veins. CONCLUSIONS: Endovascular recanalization for nonmalignant symptomatic IVC and associated iliofemoral venous obstruction with balloon angioplasty and self-expanding stents is technically challenging; however, it is safe and durable. In our retrospective study, estimated patency rates at 36 months were >85%, and clinical outcomes were excellent. Venous stenting should be attempted for chronic nonmalignant IVC and associated iliac or iliofemoral venous obstructions before open surgical reconstruction is contemplated.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Erben Y, Bjarnason H, Oladottir GL, et al. Endovascular recanalization for nonmalignant obstruction of the inferior vena cava. J Vasc Surg Venous Lymphat Disord. 2018. PMID: 29337042. doi:10.1016/j.jvsv.2017.10.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。